The ARK side of the cell: Kinases, metabolism, and therapeutic potential in malignancies

Viviana Coliboro-Dannich1, Alejandro Farías1, Luis Espinoza-Francine1

  • 1Laboratorio de Transducción de Señales y Cáncer, Departamento de Bioquímica y Biología Molecular, Facultad Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.

Pharmacological Research
|December 4, 2025
PubMed

Insights

AMP-activated protein kinase (AMPK)-related kinases (ARKs) are vital for cellular energy and stress responses. This review explores ARKs

Area of Science:

  • Molecular biology
  • Cellular signaling
  • Metabolic regulation

Background:

  • AMPK-related kinases (ARKs) are a family of serine/threonine kinases crucial for cellular energy homeostasis and stress response.
  • While AMPK is a well-known regulator, its paralogs (ARKs) also significantly modulate metabolic adaptation, signal transduction, and tumorigenesis.
  • ARKs are increasingly recognized for their central role in cancer cell physiology.

Purpose of the Study:

  • To provide a comprehensive overview of the human AMPK-related kinases (ARKs) family.
  • To detail ARKs' structural features, regulatory mechanisms, and activation pathways.
  • To categorize ARKs based on shared molecular mechanisms and tumorigenic roles in cancer.

Main Methods:

  • Literature review and synthesis of existing research on ARKs.
  • Categorization of ARKs based on molecular mechanisms and cancer-related functions.
  • Analysis of ARKs' involvement in metabolic adaptation and stress signaling.

Main Results:

  • ARKs are involved in diverse cellular processes, particularly energy metabolism and stress signaling.
  • The review categorizes ARKs, highlighting their complex and multifaceted roles in cancer.
  • ARKs represent an underappreciated layer of metabolic and stress regulation in disease.

Conclusions:

  • Understanding ARKs' functions in cancer and other diseases offers insights into cellular adaptation.
  • ARKs are emerging as significant, yet underexplored, contributors to tumor biology.
  • Knowledge of ARKs presents new opportunities for targeted cancer therapeutic strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K